TRUEMED GROUP LLC- metoprolol tartrate tablet 
Truemed Group LLC

----------

Metoprolol tartrate

Metoprolol is indicated for the treatment of angina, heart failure, myocardial infarction, atrial fibrillation, atrial flutter and hypertension.

Some off-label uses of metoprolol include supraventricular tachycardia and thyroid storm.

All the indications of metoprolol are part of cardiovascular diseases. These conditions correspond to a number of diseases that involve the function of the heart and blood vessels. The underlying causes of these conditions are variable and can be due to genetic disposition, lifestyle decisions such as smoking, obesity, diet, and lack of exercise, and comorbidity with other conditions such as diabetes. The cardiovascular diseases are the leading cause of death on a global scale

Caja

TRUEMED GROUP LLC 
metoprolol tartrate tablet
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:82922-001
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
METOPROLOL TARTRATE (UNII: W5S57Y3A5L) (METOPROLOL - UNII:GEB06NHM23) METOPROLOL TARTRATE100 mg  in 100 mg
Product Characteristics
ColorwhiteScore2 pieces
ShapeOVALSize47mm
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:82922-001-0120 mg in 1 BLISTER PACK; Type 0: Not a Combination Product09/17/2022
Image of Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Export only09/17/2022
Labeler - Truemed Group LLC (004154534)
Establishment
NameAddressID/FEIBusiness Operations
Truemed Group LLC004154534manufacture(82922-001) , label(82922-001) , pack(82922-001)

Revised: 8/2022
 
Truemed Group LLC